Biopeak has bagged $2.7 Mn (INR 24.8 Cr) in a fresh funding round led by Nikhil Kamath’s venture capital firm NKSquared, which is an existing investor in the startup
The fresh capital will be channelled towards scaling operations, including the launch of a new flagship centre in Bengaluru as well as expand its team
Founded in 2024 by Rishi Pardal and Shiva Subramanian, Biopeak offers comprehensive healthcare with cellular insights, imaging, and AI for personalised health and long-term vitality
Longevity-focussed healthtech startup Biopeak
has bagged $2.7 Mn (INR 24.8 Cr) in a fresh funding round led by Nikhil Kamath’s venture capital firm NKSquared, which is an existing investor in the startup.
The fresh capital will be channelled towards scaling operations, including the launch of a new flagship centre in Bengaluru as well as expand its team. Besides, Biopeak also intends to expand its specialist clinics and diagnostics footprint, advance proprietary AI and research infrastructure and deepen its clinical governance and advisor network.
Founded in 2024 by Rishi Pardal and Shiva Subramanian, Biopeak offers comprehensive healthcare with cellular insights, imaging, and AI for personalised health and long-term vitality, its website says. The startup is working on a tech that detects risks early, maps the body’s internal state and generates personalised insights based on an individual’s biology and lifestyle.
Its tech sees it profile 130+ biomarker blood panels, genetic and epigenetic profiling, gut and oral microbiome mapping, hormonal analysis, salivary cortisol rhythms, and whole-exome functional genomics, paired with high-resolution imaging such as MRI, CT, DXA, ECHO, and Carotid IMT.
Moreover, Biopeak collaborates with institutions like IISc and Longevity India to better contextualise healthspan data for South Asian genetics, environment, and lifestyle. This helps it provide greater relevance and accuracy in care.
The Bengaluru-based startup had launched its first longevity clinic in its home city last year. Its primary customer base includes young professionals and affluent individuals, particularly women, for whom it has created specialised modules that analyse health, skin and gut longevity, advanced imaging for silent degeneration, and other critical areas.
The startup had previously raised $1.4 Mn from Kamath in August 2024, part of a $3.5 Mn seed round led by Accel’s Prashanth Prakash, with participation from Ranjan Pai’s Claypond Capital that was announced in July last year.
The investment comes at a time when longevity and precision healthcare itself has become a point of focus for entrepreneurs globally, and Indian companies are not falling behind. Deepinder Goyal, who recently stepped down from the helm of Eternal to pursue passion projects, is betting big on the sector with Temple, which is working on wearable devices that monitor brain health and oxygen levels.
Many smart wearables startups, including Ultrahuman, Gabit, Noise, and FITTR are also entering this arena, developing smart rings that track health metrics such as sleep, stress and nutrients. Similarly, Gurugram-based Sychedelic recently launched a neuromodulation-based smart headphone to improve sleep and focus, along with tracking heart rate and stress levels.
Broadly, AI-led precision healthcare is also gaining traction with investors as well. For instance, oncology-focussed healthcare startup 4baseCare raised a $9.3 Mn investment this week. The startup creates databases that combine large-scale genomic data with clinical, environmental, and lifestyle information to enhance precision medicine.
